Primary Site >> Biliary tract Cancer
Gene >> SLC22A1
| 1. | |||||||||||
| Journal: | Int J Oncol. 2013 Apr;42(4):1297-304. | ||||||||||
| Title: | Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma. | ||||||||||
| Author: | Lautem, Anja|Heise, Michael|Grasel, Andreas|Hoppe-Lotichius, Maria|Weiler, Nina|Foltys, Daniel|Knapstein, Johanna|Schattenberg, Jorn M|Schad, Arno|Zimmermann, Anca|Otto, Gerd|Lang, Hauke|Galle, Peter R|Schuchmann, Marcus|Zimmermann, Tim | ||||||||||
| PMID: | 23440379 | ||||||||||
| 2. | |||||||||||
| Journal: | Hepatology. 2013 Sep;58(3):1065-73. | ||||||||||
| Title: | Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib. | ||||||||||
| Author: | Herraez, Elisa|Lozano, Elisa|Macias, Rocio I R|Vaquero, Javier|Bujanda, Luis|Banales, Jesus M|Marin, Jose J G|Briz, Oscar | ||||||||||
| PMID: | 23532667 | ||||||||||
| 3. | |||||||||||
| Journal: | J Control Release. 2015 Oct 28;216:93-102. | ||||||||||
| Title: | Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT). | ||||||||||
| Author: | Lozano, Elisa|Monte, Maria J|Briz, Oscar|Hernandez-Hernandez, Angel|Banales, Jesus M|Marin, Jose J G|Macias, Rocio I R | ||||||||||
| PMID: | 26278512 | ||||||||||